IDEAS home Printed from https://ideas.repec.org/a/vid/yearbk/v1y2003i1p197-213.html
   My bibliography  Save this article

Austrian health expenditures exhibit an age profile

Author

Listed:
  • Monika Riedel
  • Maria M. Hofmarcher

Abstract

We compute an age profile for public expenditures on health by calculating separate spending profiles for inpatient care, physician services and pharmaceuticals for the year 2000. We further employ three demographic scenarios to project age-related expenditures between 2000 and 2050. The Austrian profile exhibits that expenditures rise noticeably with age. For instance, per capita expenses for the 85-89 age group are about five times as high as in the 35-39 one. This pattern is also found in other EU countries. At 2.9% of GDP, inpatient care accounts for more than half of the total Austrian public expenditures on health and thus the shape of age-related inpatient care expenditures dominates the age profile. As opposed to inpatient care, we find that the profile for physician services shows a roughly linear increase, indicating that expenditures here grow rather in proportion to increasing age. However, the age profile for expenses on medical drugs is even steeper than that for inpatient care, which corroborates observed growth patterns in pharmaceutical care and heightens the age profile for public expenditures. During the next decades the shift in the age structure will cause a shift of expenditure shares. The share of public expenditures on health spent on the 80+ population group will have more than doubled by 2050. At 4.9% of GDP in 2000, public expenditures on health are predicted to increase until 2050 to 6.4% in the central population scenario, to 6.0% in the high population scenario and to 6.7% in the high life expectancy scenario.

Suggested Citation

  • Monika Riedel & Maria M. Hofmarcher, 2003. "Austrian health expenditures exhibit an age profile," Vienna Yearbook of Population Research, Vienna Institute of Demography (VID) of the Austrian Academy of Sciences in Vienna, vol. 1(1), pages 197-213.
  • Handle: RePEc:vid:yearbk:v:1:y:2003:i:1:p:197-213
    as

    Download full text from publisher

    File URL: https://epub.oeaw.ac.at/0xc1aa500d_0x0002f4cd
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Doblhammer, Gabriele & Kytir, Josef, 2001. "Compression or expansion of morbidity? Trends in healthy-life expectancy in the elderly Austrian population between 1978 and 1998," Social Science & Medicine, Elsevier, vol. 52(3), pages 385-391, February.
    2. Matthew D. Shapiro & Irving Shapiro & David W. Wilcox, 1999. "Quality Improvement in Health Care: A Framework for Price and Output Measurement," American Economic Review, American Economic Association, vol. 89(2), pages 333-337, May.
    3. David M. Cutler & Mark McClellan & Joseph P. Newhouse & Dahlia Remler, 1996. "Are Medical Prices Declining?," NBER Working Papers 5750, National Bureau of Economic Research, Inc.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Robert J. Gordon, 2000. "The Boskin Commission Report and its Aftermath," NBER Working Papers 7759, National Bureau of Economic Research, Inc.
    2. Xue Song & William D. Marder & Robert Houchens & Jonathan E. Conklin & Ralph Bradley, 2009. "Can A Disease-Based Price Index Improve the Estimation of the Medical Consumer Price Index?," NBER Chapters, in: Price Index Concepts and Measurement, pages 329-368, National Bureau of Economic Research, Inc.
    3. Berndt Ernst R. & Cockburn Iain M. & Cocks Douglas L. & Epstein Arnold M. & Griliches Zvi, 1998. "Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs," Forum for Health Economics & Policy, De Gruyter, vol. 1(1), pages 1-45, January.
    4. Michael J. Boskin, 1998. "Consumer Prices, the Consumer Price Index, and the Cost of Living," Journal of Economic Perspectives, American Economic Association, vol. 12(1), pages 3-26, Winter.
    5. Patricia M. Danzon & Allison Percy, 1999. "The Effects of Price Regulation on Productivity in Pharmaceuticals," NBER Chapters, in: International and Interarea Comparisons of Income, Output, and Prices, pages 371-418, National Bureau of Economic Research, Inc.
    6. Ernst R. Berndt & David M. Cutler & Richard Frank & Zvi Griliches & Joseph P. Newhouse & Jack E. Triplett, 2001. "Price Indexes for Medical Care Goods and Services -- An Overview of Measurement Issues," NBER Chapters, in: Medical Care Output and Productivity, pages 141-200, National Bureau of Economic Research, Inc.
    7. David M. Cutler & Mark McClellan & Joseph P. Newhouse, 1998. "Prices and Productivity in Managed Care Insurance," NBER Working Papers 6677, National Bureau of Economic Research, Inc.
    8. Richard G. Frank & Ernst R. Berndt & Susan H. Busch, 1998. "Price Indexes for the Treatment of Depression," NBER Working Papers 6417, National Bureau of Economic Research, Inc.
    9. David M. Cutler & Ellen Meara, 1998. "The Medical Costs of the Young and Old: A Forty-Year Perspective," NBER Chapters, in: Frontiers in the Economics of Aging, pages 215-246, National Bureau of Economic Research, Inc.
    10. Ruolz Ariste & Livio Di Matteo, 2017. "Value for money: an evaluation of health spending in Canada," International Journal of Health Economics and Management, Springer, vol. 17(3), pages 289-310, September.
    11. Ruben Castro, 2012. "Educational differences in chronic conditions and their role in the educational differences in overall mortality," Demographic Research, Max Planck Institute for Demographic Research, Rostock, Germany, vol. 27(12), pages 339-364.
    12. Fanny A. Kluge & Emilio Zagheni & Elke Loichinger & Tobias C. Vogt, 2014. "The advantages of demographic change after the wave: fewer and older, but healthier, greener, and more productive?," MPIDR Working Papers WP-2014-003, Max Planck Institute for Demographic Research, Rostock, Germany.
    13. Charles I. Jones, 2016. "Life and Growth," Journal of Political Economy, University of Chicago Press, vol. 124(2), pages 539-578.
    14. Frank R. Lichtenberg, 1998. "Pharmaceutical Innovation, Mortality Reduction, and Economic Growth," NBER Working Papers 6569, National Bureau of Economic Research, Inc.
    15. Gianluca Baio & Laura Magazzini & Claudia Oglialoro & Fabio Pammolli & Massimo Riccaboni, 2005. "Medical Devices: Competitiveness and Impact on Public Health Expenditure," Working Papers CERM 05-2005, Competitività, Regole, Mercati (CERM).
    16. Paolo Melindi-Ghidi & Willem Sas, 2015. "Invest as you go: how public health investment keeps pension systems healthy," Working Papers of Department of Economics, Leuven 502095, KU Leuven, Faculty of Economics and Business (FEB), Department of Economics, Leuven.
    17. Heger, Dörte & Kolodziej, Ingo W.K., 2016. "Changes in morbidity over time: Evidence from Europe," Ruhr Economic Papers 640, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    18. Justin Polchlopek, 2011. "Medical Expenditure Growth and the Diffusion of Medical Technology," Working Paper Series, Department of Economics, University of Utah 2011_10, University of Utah, Department of Economics.
    19. Sharon Kozicki, 1997. "The productivity growth slowdown: diverging trends in the manufacturing and service sectors," Economic Review, Federal Reserve Bank of Kansas City, issue Q I, pages 31-46.
    20. Rubén Castro, 2011. "About the role of chronic conditions onto the US educational differences on mortality," Working Papers 19, Facultad de Economía y Empresa, Universidad Diego Portales.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:vid:yearbk:v:1:y:2003:i:1:p:197-213. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Bernhard Rengs (email available below). General contact details of provider: https://www.oeaw.ac.at/vid/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.